, pub-5167539840471953, DIRECT, f08c47fec0942fa0

The Untold Story: CDC’s Controversial Decision on COVID Vaccine Risks Revealed

The nation’s premier health watchdog, the Centers for Disease Control and Prevention (CDC), raised eyebrows with its decision not to issue a public alert on the potential link between COVID-19 vaccines and myocarditis. In an exclusive email obtained by The Epoch Times, the veil is lifted on the internal debate that led to this controversial choice.

The Missed Warning: Unraveling CDC’s Internal Dilemma
In the email dated May 25, 2021, CDC official Dr. Sara Oliver disclosed the internal struggle over whether to send an alert through the Health Alert System (HAN). The reluctance stemmed from fears of causing panic, a revelation that has ignited criticism and accusations of negligence.

Senator Ron Johnson’s Scathing Rebuke
Senator Ron Johnson (R-Wis.), the leading Republican on the Senate Homeland Security and Governmental Affairs Committee’s Permanent Subcommittee on Investigations, minced no words in condemning the CDC’s decision. He called it “inexcusable malpractice” and emphasized the paramount importance of prioritizing public health over beaurocratic image concerns.

Transparency Troubles: A Pattern Emerges
Drug safety advocate Kim Witczak pointed to a troubling pattern of transparency issues within health agencies and pharmaceutical companies. She expressed disbelief that officials were hesitant to sound the alarm, emphasizing the need to inform the public about potential health risks.

CDC’s Selective Communication: Moderna and Pfizer in the Loop
The internal email trail reveals that CDC officials communicated with representatives from Moderna and Pfizer ahead of public disclosure. Dr. Oliver’s warning to the vaccine manufacturers, shared in emails obtained by The Epoch Times, raises questions about the extent of collaboration and the delicate balance between transparency and managing public perception.

The Myth of Mild Cases: Cardiologists Weigh In
CArdiologists dispute the notion of “mild” cases of heart inflammation, contrary to initial statements made by health officials. Research now suggests that myocarditis cases may persist for months, challenging the CDC’s earlier assertions.

FDA’s Role: Influencing the Decision
The CDC’s decision not to issue the alert after consulting with the U.S. Food and and Drug Administration (FDA) underscores the complex interplay between regulatory bodies. While the FDA declined to delve into specifics, emphasizing collaborative monitoring, questions linger about the extent of its influence on the controversial decision.

The Aftermath: Postponed Alert and Altered Narrative
Instead of the proposed alert, the CDC opted for a scaled-down online release titled “clinical considerations.” Critics argue that this approach fell short of adequately informing healthcare professionals and the public about the potential risks associated with mRNA COVID-19 vaccines.

In a post-pandemic landscape where trust in public health entities is paramount, the CDC’s decision-making processes face renewed scrutiny. The delicate dance between transparency and avoiding panic has left many wondering about the true cost of prioritizing public image over public health.

Free Speech and Alternative Media are under attack by the Deep State. Real News Cast needs reader support to survive. 

Every dollar helps. Contributions help keep the site active and help support the author (and his medical bills)

Please Contribute via  GoGetFunding